Cargando…

Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients?

Detalles Bibliográficos
Autor principal:	Ali, Nurshad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241387/ https://www.ncbi.nlm.nih.gov/pubmed/32471656 http://dx.doi.org/10.1016/j.clinre.2020.05.002

Ejemplares similares

Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)
por: Li, Xiaofei
Publicado: (2021)

The study of olfactory dysfunction in SARS-CoV-2 variants
por: Vaira, Luigi A., et al.
Publicado: (2022)

Reply to: Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)
por: López-Mendez, Ivan, et al.
Publicado: (2021)

Clinical Manifestation and the Risk of Exposure to SARS-CoV-2 (COVID-19)
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2020)

Duration for carrying SARS-CoV-2 in COVID-19 patients
por: Du, Xinwei, et al.
Publicado: (2020)

Characteristics of SARS-CoV-2 exhaled by COVID-19 patients
por: Lina, Liu, et al.
Publicado: (2023)

Transmission and prevention of SARS-CoV-2 (COVID-19) in prisons
por: Iglesias-Osores, S
Publicado: (2020)

The role of epidemiologists in SARS-CoV-2 and COVID-19 research
por: Oremus, M., et al.
Publicado: (2021)

Significance of physiotherapy in “SARS-CoV-2/COVID-19: An Epidemic”
por: Jangra, Mandeep Kumar, et al.
Publicado: (2020)

Suggesting Ritonavir against COVID-19/SARS-CoV-2
por: Choudhury, Shuvasish, et al.
Publicado: (2020)

Intrauterine Transmission of SARS-CoV-2 (COVID-19 Virus)
por: agarwal, Mukta, et al.
Publicado: (2021)

Reinfections with SARS-CoV-2 or second COVID-19 episodes?
por: Cabrera-Gaytán, David Alejandro, et al.
Publicado: (2021)

No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease
por: Biquard, Louise, et al.
Publicado: (2020)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Reply to: Correspondence relating to “SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19”
por: Wang, Yijin, et al.
Publicado: (2020)

Ratcheting down the virulence of SARS‐CoV‐2 in the COVID‐19 pandemic
por: Brufsky, Adam, et al.
Publicado: (2020)

Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19
por: Colson, Philippe, et al.
Publicado: (2021)

Could SARS-CoV-2 or COVID-19 Be a Biological Weapon?
por: DEHGHANI, Arezoo, et al.
Publicado: (2020)

Covid-19 convalescent plasma and SARS-CoV-2 viral variants
por: Joob, B., et al.
Publicado: (2021)

Reply to: ‘No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease’
por: Ji, Dong, et al.
Publicado: (2020)

Quantification of SARS-CoV-2 antigen levels in the blood of patients with COVID-19
por: Su, Bin, et al.
Publicado: (2020)

Host transcriptional response to SARS‐CoV‐2 infection in COVID‐19 patients
por: Singh, Nitesh Kumar, et al.
Publicado: (2021)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!
por: Guarino, Maria, et al.
Publicado: (2022)

SARS-CoV-2: Is the liver merely a bystander to severe disease?
por: Bangash, Mansoor N., et al.
Publicado: (2020)

SARS-CoV-2 related liver impairment – perception may not be the reality
por: Philips, Cyriac Abby, et al.
Publicado: (2020)

Unexplained liver test elevations after SARS-CoV-2 vaccination
por: Guardiola, John, et al.
Publicado: (2022)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Myocardial dysfunction in SARS-CoV-2 infection in infants under 1 year of age
por: Taksande, Amar
Publicado: (2020)

Author’s reply to the Letter to the Editor “The study of olfactory dysfunction in SARS-CoV-2 variants”
por: Hintschich, Constantin A., et al.
Publicado: (2022)

Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients
por: Zhang, Bao-zhong, et al.
Publicado: (2020)

Disappearance of antibodies to SARS-CoV-2 in a -COVID-19 patient after recovery
por: Liu, Anding, et al.
Publicado: (2020)

Persistence of anti-SARS-CoV-2 IgM in convalescent COVID-19 patients
por: Yan, Xiquan, et al.
Publicado: (2021)

Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients
por: Morales-Ortega, Alejandro, et al.
Publicado: (2022)

Dynamic changes of serum SARS-CoV-2 antibody levels in COVID-19 patients
por: He, Lu, et al.
Publicado: (2022)

COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF
por: Andriuta, Daniela, et al.
Publicado: (2020)

Don’t forget ototoxicity during the SARS-CoV-2 (Covid-19) pandemic!
por: Ciorba, Andrea, et al.
Publicado: (2020)

Defensin 5 for prevention of SARS-CoV-2 invasion and Covid-19 disease
por: Niv, Yaron
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_olnm0087enmh7fl0v9lhtihd47